HIGHLIGHTS
- who: u2022 and collaborators from the Tokyo, Japan , Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan have published the research: A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial), in the Journal: (JOURNAL)
- what: This study assessed the efficacy of chemoradiotherapy for squamous cell carcinoma of the anal canal (SCCAC). The aim of this study was to estimate the 2-year DFS and 95% confidence interval (CI).
SUMMARY
Abdominopelvic CT, chest . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.